14
Jul

Targacept kept the faith in its late-stage Alzheimer’s disease drug after ex-partner AstraZeneca walked away from the treatment, but a new mid-stage failure has forced the biotech to pull the plug on TC-1734.

…read more

Source: Targacept’s Alzheimer’s hopeful misses the mark in Phase II

    

0 No comments